Clinical trial
A Phase II, Open-Label Extension Study of Patients Previously Enrolled in Study GA30044 to Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Patients With Moderate to Severe Active Systemic Lupus Erythematosus
NCT03407482 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II, Open-Label Extension Study of Patients Previously Enrolled in Study GA30044 to Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Patients With Moderate to Severe Active Systemic Lupus Erythematosus
- Lead sponsor
- Genentech, Inc.
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- January 9, 2018
- Completion date
- November 20, 2019
- Enrollment
- 160 (actual)
- Sites
- 53
Conditions
As the registry lists them; a condition with its own page is linked.